Results for second quarter and first half of 2019 for Medistim ASA

Sales ended at MNOK 93.7 for the quarter (MNOK 76.2), a 23.1 % increase. Sales for the 1st half increased by 21.4 % and ended at MOK 182.5 (MNOK 150.4). Currency neutral growth of own products was 20.5 % for the quarter. Currency neutral growth of own products was 20.4 % for the 1st half. Operating profit (EBIT) for the quarter ended at MNOK 30.9, a 70.4 % growth (MNOK 18.1). Operating profit for the 1st half ended at MNOK 50.8, a 60.3 % growth (MNOK 31.7). Another strong quarter in the US with a growth in NOK of 54.4 %. Growth for the first half was in NOK 52.4 %. Currency neutral growth for the quarter was 42.2 % and 40.4 % for the first half. The final results from the REQUEST register study were presented at AATS in Toronto. Dividend based upon 2018 results was paid the second quarter with MNOK 40.9, NOK 2.25 per share (NOK 2.00 per share).